The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor.
about
Role of sialic acid for platelet life span: exposure of beta-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes.Mutations in intron 1 and intron 22 inversion negative haemophilia A patients from Western India.Soy phosphatidylinositol containing nanoparticle prolongs hemostatic activity of B-domain deleted factor VIII in hemophilia A mice.PEGylation of a factor VIII-phosphatidylinositol complex: pharmacokinetics and immunogenicity in hemophilia A mice.A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytesAssociation of Single Nucleotide Polymorphisms in the ST3GAL4 Gene with VWF Antigen and Factor VIII Activity.The pharmacokinetics of coagulation factors.Clearance mechanisms of von Willebrand factor and factor VIII.O-phospho-L-serine, multi-functional excipient for B domain deleted recombinant factor VIII.Inhibitor development.Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014.Role of glycosylation in conformational stability, activity, macromolecular interaction and immunogenicity of recombinant human factor VIIIThe C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells.Missense mutations near the N-glycosylation site of the A2 domain lead to various intracellular trafficking defects in coagulation factor VIII.BAY 81-8973, a full-length recombinant factor VIII: manufacturing processes and product characteristics.Baby hamster kidney cell-derived recombinant factor VIII: a quarter century of learning and clinical experience.Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.Improved Pharmacokinetics with BAY 81-8973 Versus Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method: A Randomized Pharmacokinetic Study in Patients with Severe Hemophilia A.Therapeutic factor VIII does not trigger TLR1.2 and TLR2.6 signalling in vitro.Predictive immunogenicity of Refacto AF.Pharmacokinetic properties of BAY 81-8973, a full-length recombinant factor VIII.Safety and efficacy of BAY 81-8973 for surgery in previously treated patients with haemophilia A: results of the LEOPOLD clinical trial programme.Characterizing the glycosylation state of therapeutic recombinant glycoproteins.Ca(2+) concentration-dependent conformational change of FVIII B-domain observed by atomic force microscopy.
P2860
Q33384971-232388BB-83DB-4DA1-9F92-197DE3A5D4C6Q33638398-3E9556E2-6634-47D0-AEE0-4E8E4262DAE0Q34283156-2F0853F1-E099-4D42-92F2-2E8E7C1F4790Q35793113-B4CAB6CC-0232-417E-9E0F-A0A82EC33FA5Q35829158-9FB97376-D15C-4BED-879F-E58DE2813A50Q36120096-2C775C67-DD19-4F8C-BB1C-14C90047C7D4Q36473015-788EBB50-4C3C-45A0-B2DC-CE8C034A2D9BQ36787433-C023C9DA-C52E-43D5-922F-6144C0ABCA21Q36950100-F132129D-05F0-465D-AEC9-4EDDB5F59207Q37176486-ED9226BA-F533-48C9-9003-BF48AEBB10BEQ37185097-7764F285-F930-4017-A3B6-19B32E8971C6Q37378039-1AC08CA0-D669-4EAE-B205-FC14696EA91AQ37618821-FFEC00D2-3B81-438A-A080-E352EDD83A37Q37715039-EB43D123-CC41-43AF-984F-4ADFC075F747Q38725317-D0C1F7FC-82FF-4941-86E6-2D6BE2CA21D1Q38731189-9148B363-B81D-481C-BB3A-5EB6AE821BAEQ38944642-4069E634-F4E2-46FA-B233-AC4C2E691149Q39074627-13E4B58A-54CF-4666-9858-ED497B8028D1Q39223774-A2D67E58-8662-4A7D-A566-0ECC52474421Q45861147-31F66AD6-79C4-4FB5-88F7-922A5CC7352FQ45875765-61D4E90D-19C4-4602-B52D-38CC0BF21F72Q45883680-C108BFAD-7E26-4243-9412-E537341BCA26Q45884176-54716823-27E6-48C1-9044-496EAA187359Q53496690-5BA86CB2-91BF-479D-BD5D-68D1B0E2A3FB
P2860
The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor.
@en
type
label
The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor.
@en
prefLabel
The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor.
@en
P2093
P1476
The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor.
@en
P2093
Bovenschen N
Havekes LM
van Vlijmen BJ
P304
P356
10.1111/J.1538-7836.2005.01389.X
P577
2005-06-01T00:00:00Z